Overview

Chidamide Plus R-CHOP in Elderly DLBCL

Status:
Unknown status

Trial end date:
2019-04-01

Target enrollment:

Participant gender:

Summary

This is a prospective, single-arm, open-label phase II study of Chidamide in combination with R-CHOP in the treatment of de novo, elderly, high-risk diffuse large B cell lymphoma patients.

Phase:

Phase 2

Details

Lead Sponsor:

Ruijin Hospital

Treatments:

Cyclophosphamide
Doxorubicin
Liposomal doxorubicin
Prednisone
Rituximab
Vincristine